# US Biotech Depends on Chinese Science. Washington Wants It to Stop. - Date: 2026-03-31 - Category: Biotech & Life Sciences Chinese academic labs are now the most contested real estate in drug development. US investors need scientists to publish; Chinese investors need them to stay quiet — and both sides are racing to get there first. ---